Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass

Javaid Iqbal1, Chun Shing Kwok1, Evangelos Kontopantelis1

  • 1From the Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK (J.I.); Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK (C.S.K., M.A.M.); Department of Cardiology, Royal Stoke Hospital, University Hospital North Midlands NHS Trust, UK (C.S.K., M.G., M.A.M.); Farr Institute, University of Manchester, Manchester, UK (E.K., M.A.M.); Department of Cardiology, The James Cook University Hospital, Middlesbrough, UK (M.A.d.B.); Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK (P.F.L.); and Department of Cardiology, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK (M.G., A.Z.).

Insights

Patients with prior coronary artery bypass grafting (CABG) undergoing primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI) do not face increased mortality risk. Prior CABG is a marker for other high-risk features, not an independent risk factor.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Limited data exists on outcomes for ST-elevation myocardial infarction (STEMI) patients with prior coronary artery bypass grafting (CABG) undergoing primary percutaneous coronary intervention (PPCI).
  • Real-world data on this specific patient population is scarce.

Purpose of the Study:

  • To evaluate the outcomes of patients with STEMI undergoing PPCI, comparing those with and without a history of CABG.
  • To determine if prior CABG independently impacts mortality and adverse events in STEMI patients treated with PPCI.

Main Methods:

  • A large, real-world, all-comer dataset from England and Wales (2007-2012) was analyzed.
  • Clinical, demographic, procedural, and outcomes data for STEMI patients undergoing PPCI were collected.
  • All-cause mortality at 30 days and 1 year were assessed in the overall and propensity-matched cohorts.

Main Results:

  • Of 79,295 STEMI patients, 2,658 (3.4%) had prior CABG, with PPCI performed on native vessels (44%) or bypass grafts (56%).
  • Patients with prior CABG showed higher unadjusted 30-day mortality (6.2-6.1%) compared to those without (4.5%; P<0.001).
  • After risk factor adjustment and in propensity-matched analysis, no significant difference in 30-day mortality or major adverse cardiovascular events was observed between groups.

Conclusions:

  • A history of CABG in STEMI patients undergoing PPCI does not independently increase mortality risk.
  • Prior CABG serves as an indicator of other underlying high-risk characteristics in these patients.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
558
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
431
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
543
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
409
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.0K